G-CURE aims to become a global scientific leader in the development of new (pharmacological) treatments for cardiovascular diseases with a focus on heart failure, preservation of left ventricular function after acute myocardial infarction and atrial fibrillation.
We offer our unique skill sets and combined expertise to pharmaceutical, biotech and related industries, with services ranging from experimental animal studies to the creation of marketing authorisation dossiers.